- Home
- YORW vs AVIR Comparison
YORW vs AVIR Comparison
Compare YORW & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YORW | AVIR |
|---|---|---|
| Founded | 1816 | 2012 |
| Country | United States | United States |
| Employees | 104 | N/A |
| Industry | Water Supply | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 466.4M | 450.9M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | YORW | AVIR |
|---|---|---|
| Price | $30.44 | $5.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $34.00 | $10.00 |
| AVG Volume (30 Days) | 151.1K | ★ 335.5K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ 1.39 | N/A |
| Revenue | $77,488,000.00 | ★ $351,367,000.00 |
| Revenue This Year | $11.78 | N/A |
| Revenue Next Year | $4.95 | N/A |
| P/E Ratio | $21.80 | ★ N/A |
| Revenue Growth | ★ 3.37 | N/A |
| 52 Week Low | $28.26 | $2.46 |
| 52 Week High | $36.48 | $6.45 |
Technical Indicators
Market Signals| Indicator | YORW | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 41.59 | 53.63 |
| Support Level | $29.97 | $3.28 |
| Resistance Level | $32.59 | $6.37 |
| Average True Range (ATR) | 0.74 | 0.24 |
| MACD | -0.06 | -0.03 |
| Stochastic Oscillator | 49.88 | 50.52 |
Price Performance
Historical ComparisonAbout YORW York Water Company (The)
The York Water Co is the investor-owned water utility in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. The company also owns and operates three wastewater collection systems and twelve wastewater collection and treatment systems. The company operates within its franchised water and wastewater territory, which covers portions of municipalities within four counties in south-central Pennsylvania. It provides services to diversified, manufacturing such items as fixtures and furniture, electrical machinery, food products, paper, ordnance units, textile products, air conditioning systems, laundry detergent, barbells, and motorcycles.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.